UPDATED Mar 28, 2024
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
NVDA | US$903.56 | -1.2% | 230.0% | US$2.2t | US$955.60 | PE74.7x | E22.9% | 0.02% | Semiconductors | ||
ALNY | US$149.45 | 1.9% | -23.4% | US$19.4b | US$220.76 | PS10.3x | E60.8% | n/a | Pharmaceuticals & Biotech | ||
ELF | US$196.03 | -5.4% | 148.4% | US$10.9b | US$208.21 | PE84.1x | E30.8% | n/a | Household | ||
NU | US$11.93 | -2.5% | 148.0% | US$57.0b | US$12.08 | PB8.9x | E38.6% | n/a | Banks | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
PDD | US$116.25 | -4.9% | 52.1% | US$155.0b | US$180.97 | PE18.6x | E22.9% | n/a | Retail | ||
BX | US$131.37 | -0.2% | 53.2% | US$153.6b | US$127.70 | PE67.5x | E29.9% | 2.6% | Diversified Financials | ||
LI | US$30.28 | -4.0% | 19.6% | US$30.2b | US$53.51 | PE18.7x | E22.7% | n/a | Automobiles | ||
CG | US$46.91 | -1.0% | 55.1% | US$16.9b | US$50.07 | PS7x | E23.6% | 3.0% | Diversified Financials | ||
SMCI | US$1,010.03 | 4.0% | 877.4% | US$59.9b | US$919.37 | PE80.7x | E35.3% | n/a | Tech | ||
SYM | US$45.00 | -7.0% | 103.0% | US$26.4b | US$53.93 | PS3.2x | E115.4% | n/a | Capital Goods | ||
CELH | US$82.92 | -8.8% | 172.0% | US$19.4b | US$92.30 | PE106.1x | E23.5% | n/a | Food, Beverage & Tobacco | ||
PTC | US$188.94 | -0.4% | 50.3% | US$22.7b | US$198.40 | PE95.4x | E24.2% | n/a | Software | ||
RYAN | US$55.50 | -0.09% | 40.0% | US$14.5b | US$54.11 | PE108x | E50.2% | 0.8% | Insurance | ||
ONON | US$35.38 | -0.6% | 14.8% | US$11.1b | US$35.20 | PE127.8x | E28.1% | n/a | Consumer Durables | ||
ARES | US$132.98 | -2.6% | 63.5% | US$41.3b | US$143.55 | PE56.8x | E36.3% | 2.8% | Diversified Financials | ||
SRPT | US$129.46 | 3.6% | -4.8% | US$12.2b | US$164.33 | PS9.8x | E41.9% | n/a | Pharmaceuticals & Biotech | ||
VRT | US$81.67 | -0.5% | 491.8% | US$30.9b | US$73.48 | PE67.8x | E29.9% | 0.1% | Capital Goods | ||
SPOT | US$263.90 | 1.6% | 101.7% | US$51.6b | US$268.22 | PS3.7x | E46.9% | n/a | Media | ||
TER | US$112.83 | 1.2% | 4.9% | US$17.1b | US$112.15 | PE38.5x | E20.8% | 0.4% | Semiconductors | ||
ZS | US$192.63 | -2.7% | 71.7% | US$29.0b | US$259.48 | PS15.2x | E41.0% | n/a | Software | ||
CRWD | US$320.59 | -2.7% | 143.4% | US$77.9b | US$390.31 | PE868.1x | E34.7% | n/a | Software | ||
TEAM | US$195.11 | -1.1% | 21.5% | US$50.1b | US$259.38 | PS13x | E43.1% | n/a | Software | ||
ARM | US$124.99 | -6.4% | n/a | US$129.1b | US$101.82 | PE1511.8x | E47.5% | n/a | Semiconductors |